Emerging Therapeutic Strategies Against Entamoeba Histolytica: Thioredoxin Reductase Inhibition and Nanoparticle-Based Drug Delivery. Al-Iraqia Medical College Journal, v. 3, n. 2, p. 22–33, 15 Aug.2026.